These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8872950)

  • 1. Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside.
    Cahill MM; Ryan GB; Bertram JF
    Kidney Int; 1996 Sep; 50(3):768-75. PubMed ID: 8872950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
    Matsumae T; Fukuzaki M; Takebayashi S; Naito S
    Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture.
    Nagata M; Schärer K; Kriz W
    Kidney Int; 1992 Jul; 42(1):136-47. PubMed ID: 1635343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
    Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
    Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF(165) mediates glomerular endothelial repair.
    Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
    J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of podocyte injury on glomerular development.
    Ma J; Rossini M; Yang HC; Zuo Y; Fogo AB; Ichikawa I
    Pediatr Res; 2007 Oct; 62(4):417-21. PubMed ID: 17667850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
    Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
    Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of elastase on aminonucleoside nephrosis--on renal vascular system].
    Ono H; Hirabayashi K; Ono Y; Sagiya A; Kanaya H; Iidaka K
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):783-8. PubMed ID: 1479717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
    Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
    Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
    Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal structural abnormalities following recovery from acute puromycin nephrosis.
    Rasch R; Nyengaard JR; Marcussen N; Meyer TW
    Kidney Int; 2002 Aug; 62(2):496-506. PubMed ID: 12110010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
    Sagar S; Gibbons N; Valderrama E; Singhal PC
    Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
    Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
    Fogo A; Yoshida Y; Glick AD; Homma T; Ichikawa I
    J Clin Invest; 1988 Jul; 82(1):322-30. PubMed ID: 3392211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
    Lee HS; Lim SD
    Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.